Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
01 May, 2026, 11.01 PM IST
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discoverySandboxAQ, an AI startup originating from Alphabet's Google and backed by Nvidia, has released a substantial dataset to accelerate drug dis...
18 Jun, 2025, 06.51 PM IST
Ahammune Biosciences raises $5 million to fund novel vitiligo therapyThe funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for vitiligo - an autoimm...
25 Sep, 2024, 04.40 PM IST
PMS funds that helped HNIs survive September shockAt least 50 PMS funds managed to eke out positive returns during the month, showed data pulled from PMSBazaar
12 Oct, 2022, 02.51 PM IST
Cipla, Kemwell Biopharma join hands to develop biosimilarsUnder the terms of the agreement, the joint venture will leverage Cipla and Kemwell’s complementary strengths for end-to-end product develo...
25 Aug, 2021, 03.54 PM IST
This firm is hunting for a cancer cureZumutor, the Boston-headquartered startup, which was founded by second-time entrepreneur and former Biocon executive Kavitha Iyer Rodrigues...
01 Dec, 2019, 10.26 AM IST
IIL's Rs 40-crore R&D facility becomes operationalThe research and development (R&D) facility is set up by OAT and IIL Laboratories Ltd, a joint venture company between IIL and Japanese fir...
25 Sep, 2014, 03.49 PM IST
- Biosimilar products development gets a USFDA norms boost
A biosimilar is a product that is similar to a biologic, which in turn is any drug produced through a biological route rather than chemical...
01 Mar, 2012, 05.21 AM IST
- US drugmaker Eli Lilly, Jubilant Life call off joint venture
US drugmaker Eli Lilly & Company and Noida-based Jubilant Life Sciences have called off their equal drug-discovery partnership to develop m...
25 Jan, 2012, 04.03 AM IST
- Shasun inks JV with US-based Nanoparticle Biochem
Shasun Pharmaceuticals Ltd has entered into a joint venture with US based Nanoparticle Biochem Inc to explore opportunities in the field of...
31 Aug, 2010, 10.59 AM IST
- TCG Lifesciences, Pfizer ink drug research pact
TCG Lifesciences, the Rs 400-crore clinical research organisation (CRO) venture of the Chatterjee Group, has entered into an exclusive coll...
06 Jan, 2010, 12.54 AM IST
- Dr Reddy’s eyes new ops for Perlecan candidates
Drug-maker Dr Reddy’s Laboratories will stop innovative drug research at Perlecan Pharma, its wholly-owned subsidiary, due to a virtual fre...
09 Oct, 2008, 12.42 AM IST
- Eli Lilly, Jubilant Organosys form R&D joint venture
Eli Lilly and Jubilant Organosys have formed a 50:50 R&D joint venture (JV) to develop molecules across several thereupatic areas.
04 Oct, 2008, 12.36 AM IST
- 'Pullout to hurt investor confidence'
This week, sources told ET that ICICI Venture and Citigroup Venture are in talks with Dr Reddy’s to pull out their investment in Perlecan o...
20 Dec, 2007, 12.06 AM IST
- PEs may exit Dr Reddy's R&D unit
ICICI Venture Funds and Citigroup Venture Capital are likely to pull out their investment in Dr Reddy’s Laboratories’ drug research company...
19 Dec, 2007, 01.21 AM IST
- DRL stops work on new diabetes drug
India’s largest drug maker, Dr Reddy’s Laboratories, has stopped further development of a new drug aimed at treating diabetes and obesity.
11 Oct, 2007, 01.59 AM IST
- UPL to form speciality products JV with Japanese cos
Agrochemicals major United Phosphorus (UPL) will set up a joint venture company with Japanese players Ishihara Sangyo Kaisha (ISK) and Mits...
28 Sep, 2006, 12.00 AM IST